Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and cysteine

gemcitabine has been researched along with cysteine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Lohman, GJ; Stubbe, J; Wang, J1
Distler, AM; Hill, EG; Lemasters, JJ; Manevich, Y; Mieyal, JJ; Nieminen, AL; Qanungo, S; Shaner, B; Townsend, DM; Uys, JD1
Bi, D; Ding, K; Ding, S; Li, J; Liu, S; Lu, J; Niu, Z; Sun, L; Wu, F; Zhang, H; Zhao, Z1

Reviews

1 review(s) available for gemcitabine and cysteine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for gemcitabine and cysteine

ArticleYear
Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Cysteine; Cytidine Diphosphate; Deoxycytidine; Enzyme Activation; Escherichia coli; Gemcitabine; Humans; Molecular Structure; Molecular Weight; Protein Binding; Protein Subunits; Ribonucleotide Reductases; Time Factors

2007
N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:7

    Topics: Acetylcysteine; Animals; Apoptosis; Cell Line, Tumor; Cysteine; Deoxycytidine; Gemcitabine; Glutathione; Humans; Male; Mice; Mice, Nude; NF-kappa B; Oxidative Stress; Pancreatic Neoplasms; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein

2014
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cluster Analysis; Cysteine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kinesins; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoside Diphosphate Reductase; RNA Interference; Trityl Compounds; Tumor Burden; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2015